Open AccessP813: EFFICACY, TREATMENT ADMINISTRATION SATISFACTION AND SAFETY OF SUBCUTANEOUS RAVULIZUMAB THROUGH 1 YEAR IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO RECEIVED PRIOR INTRAVENOUS ECULIZUMAB
Author(s) -
Yenerel M. N.,
Sicre de Fontbrune F.,
Piatek C.,
Sahin F.,
Füreder W.,
Ogawa M.,
Tomazos I.,
Doll H.,
OzolGodfrey A.,
Sierra J. R.,
Szer J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846136.56070.c0
Subject(s) - paroxysmal nocturnal hemoglobinuria , eculizumab , medicine , hemoglobinuria , randomized controlled trial , adverse effect , anemia , surgery , antibody , immunology , complement system